Category:Medication time–concentration curves

This category is for pharmacokinetic time–concentrations curves of medications.

Media in category "Medication time–concentration curves"

The following 130 files are in this category, out of 130 total.

Androgen levels with 10 or 20 mg per day oral cyproterone acetate in men.png 1,467 × 1,112; 174 KB
Bicalutamide levels after a single 10, 30, or 50 mg oral dose of bicalutamide in men.png 1,437 × 1,097; 192 KB
Bicalutamide levels after a single 50 mg oral dose of bicalutamide in men.png 1,453 × 1,101; 223 KB
Biotin levels with different doses of oral supplements at steady state.png 1,661 × 1,061; 129 KB
Comparison of bupropion levels with bupropion IR, bupropion SR, and bupropion XL.png 729 × 1,336; 103 KB
Cyproterone acetate and testosterone levels with 300 mg per week cyproterone acetate by intramuscular injection in men.png 1,825 × 1,103; 292 KB
Cyproterone acetate levels with 100 mg oral cyproterone acetate per day in women.png 1,695 × 1,106; 181 KB
Cyproterone acetate levels with 300 mg cyproterone acetate per week by intramuscular injection in men.png 1,594 × 1,092; 194 KB
Cyproterone acetate levels with a single oral dose of 100 mg cyproterone acetate in men.png 1,879 × 1,137; 219 KB
Daridorexant levels after a single oral dose of 50 to 150 mg daridorexant in recreational sedative drug users.png 1,801 × 1,287; 145 KB
Dextroamphetamine concentration-time curves after oral administration of equimolar doses of dextroamphetamine and lisdexamfetamine in adults.png 1,883 × 1,299; 141 KB
Dose-normalized nandrolone exposure with nandrolone decanoate by intramuscular or subcutaneous injection in men.png 2,370 × 1,450; 431 KB
Doxylamine levels after a single 25 mg oral dose of doxylamine.png 1,247 × 805; 76 KB
Estradiol and dehydroepiandrosterone levels after a single intramuscular injection of Gynodian Depot in women.png 1,828 × 1,097; 231 KB
Estradiol and prolactin levels after the last injection during therapy with estradiol enantate and dihydroxyprogesterone acetophenide in women.png 1,830 × 1,097; 181 KB
Estradiol and testosterone levels with 280 mg per day oral estramustine phosphate in men with prostate cancer.png 1,869 × 1,107; 260 KB
Estradiol and testosterone levels with a single intramuscular injection of 320 mg polyestradiol phosphate in men.png 1,767 × 1,108; 238 KB
Estradiol and testosterone levels with high-dose estradiol patches in men.png 2,688 × 1,679; 263 KB
Estradiol cypionate levels after a single intramuscular injection of 5 mg microcrystalline estradiol cypionate in aqueous suspension in women.png 2,176 × 1,440; 323 KB
Estradiol levels after a single 5 mg intramuscular injection of estradiol esters.png 1,983 × 1,256; 159 KB
Estradiol levels after a single dose and with continuous administration of oral estradiol or oral estradiol valerate in women.png 1,442 × 1,148; 173 KB
Estradiol levels after a single intramuscular injection of 1.0 to 2.0-mg estradiol cypionate in hypogonadal girls.png 1,956 × 1,228; 103 KB
Estradiol levels after a single intramuscular injection of 10 mg estradiol valerate and 100 mg estradiol undecylate.png 2,213 × 1,099; 260 KB
Estradiol levels after a single intramuscular injection of 50 μg per kg estradiol dipropionate in pubertal girls.png 1,615 × 1,302; 115 KB
Estradiol levels after a single oral dose of 2 mg estradiol with food in postmenopausal women.png 1,614 × 1,120; 186 KB
Estradiol levels after a single subcutaneous or intramuscular injection of 5 mg estradiol cypionate.png 1,676 × 1,062; 230 KB
Estradiol levels after an intramuscular injection of different doses of estradiol enanthate in premenopausal women.png 1,680 × 1,082; 213 KB
Estradiol levels after injections of estradiol, estradiol benzoate, estradiol valerate, and estradiol undecylate in women.png 2,196 × 1,442; 336 KB
Estradiol levels after single intramuscular injections of different doses of estradiol benzoate in premenopausal women.png 1,455 × 1,099; 186 KB
Estradiol levels at steady state with intramuscular injections of 5 mg estradiol cypionate per month in premenopausal women.png 2,031 × 1,236; 137 KB
Estradiol levels with 1 mg per day transdermal estradiol gel applied to different amounts of area in postmenopausal women.png 1,444 × 1,101; 198 KB
Estradiol levels with 1 mg single-dose or continuous oral estradiol in women.png 1,662 × 1,145; 182 KB
Estradiol levels with 1.5 or 3.0 mg per day transdermal estradiol gel in postmenopausal women.png 1,698 × 1,136; 224 KB
Estradiol levels with 10 to 200 mg per day bicalutamide monotherapy in men.png 1,567 × 1,090; 218 KB
Estradiol levels with 10, 30, and 50 mg per day bicalutamide monotherapy in men.png 1,562 × 1,099; 188 KB
Estradiol levels with 40 mg per day oral relguolix therapy in premenopausal women.png 1,439 × 992; 160 KB
Estradiol levels with a 50 or 100 μg per day transdermal estradiol patch (Climara-type) in women.png 2,035 × 1,539; 268 KB
Estradiol levels with a single application of a 100 µg per day estradiol reservoir patch (Estraderm) with and without an ethanol injection in postmenopausal women.png 2,000 × 1,372; 246 KB
Estradiol levels with a single dose of 2 mg oral estradiol micronized to different particle sizes in women.png 1,725 × 1,193; 147 KB
Estradiol levels with a transdermal estradiol emulsion (brand name Estrasorb) in postmenopausal women.png 2,314 × 1,683; 256 KB
Estradiol levels with different dosages of transdermal estradiol patches (Climara-type) in postmenopausal women.png 2,072 × 1,411; 281 KB
Estradiol levels with different dosages of transdermal estradiol patches (Vivelle-type) in postmenopausal women.png 1,671 × 1,138; 208 KB
Estradiol levels with estradiol enanthate and dihydroxyprogesterone acetophenide after single or repeated injections in premenopausal women.png 2,092 × 1,382; 257 KB
Estradiol levels with estradiol transdermal spray (brand name Lenzetto) in postmenopausal women.png 2,188 × 1,598; 265 KB
Estradiol levels with intramuscular injection of polyestradiol phosphate once every 4 weeks.png 1,653 × 1,119; 92 KB
Estradiol levels with oral micronized estradiol and oral estradiol valerate in postmenopausal women.png 2,204 × 1,425; 302 KB
Estradiol levels with oral versus sublingual estradiol in postmenopausal women.png 1,196 × 1,093; 206 KB
Estradiol levels with rectal administration of estradiol in women.png 971 × 1,082; 105 KB
Estradiol levels with sublingual estradiol in transgender women.png 1,262 × 1,069; 103 KB
Estrogen and gonadotropin levels with 0.5 mg sublingual estradiol in postmenopausal women.png 1,088 × 1,087; 184 KB
Estrogen and gonadotropin levels with 1 mg vaginal estradiol in women.png 1,179 × 1,137; 177 KB
Estrogen and gonadotropin levels with 2 mg oral estradiol in women.png 1,017 × 1,101; 165 KB
Estrogen levels after a single 300 μg dose of intranasal estradiol (Aerodiol) in postmenopausal women.png 1,457 × 1,283; 108 KB
Estrogen levels after a single intramuscular injection of 10 mg estradiol valerate in postmenopausal women.png 1,697 × 1,099; 194 KB
Estrogen levels with 1.25 g of 0.06% transdermal estradiol gel (EstroGel) per day in postmenopausal women.png 1,634 × 1,131; 176 KB
Estrogen levels with a 50 µg per day estradiol transdermal patch in postmenopausal women.png 1,656 × 1,129; 211 KB
Estrogen levels with a single vaginal application of 0.5 mg estradiol in postmenopausal women.png 1,451 × 1,129; 161 KB
Estrogen, progesterone, testosterone, and SHBG levels during pregnancy in women.png 2,048 × 1,196; 358 KB
Ethinylestradiol levels following a single 20 µg oral dose of ethinylestradiol in women.png 1,252 × 1,136; 184 KB
Hormone levels after a single 0.5 mg dose of sublingual estradiol in women.png 1,086 × 1,101; 156 KB
Hormone levels after a single 2 mg dose of sublingual estradiol in women.png 1,091 × 1,092; 187 KB
Hormone levels after a single intramuscular injection of 5 mg estradiol valerate in postmenopausal women.png 1,593 × 1,105; 227 KB
Hormone levels with low-dose estradiol gel and oral cyproterone acetate in transgender women.png 1,604 × 1,099; 173 KB
Hormone levels with oral estradiol valerate tablets (Progynova) taken sublingually in premenopausal women.png 1,409 × 1,093; 268 KB
Hydroxyprogesterone caproate levels after a final dose following continuous therapy with 250 mg per week by intramuscular injection in pregnant women.png 1,886 × 1,147; 172 KB
Hydroxyprogesterone caproate levels after a single intramuscular injection of 1,000 mg hydroxyprogesterone caproate in women.png 1,787 × 1,121; 175 KB
Idealized curves of estradiol levels after injection of different estradiol esters in women.png 1,759 × 1,261; 196 KB
Levels of elagolix following a single oral dose of different doses of elagolix in women.png 1,247 × 1,120; 183 KB
Levels of estetrol after a single dose of different doses of oral estetrol in postmenopausal women.png 1,728 × 1,140; 187 KB
Levels of estradiol and estrone over an observational period of 24 hours following 14 days of continuous low dose estrogen replacement therapy.png 1,609 × 1,123; 100 KB
Levels of estradiol with administration of a 100 mg subcutaneous implant of estradiol in women.png 1,446 × 1,058; 153 KB
Levels of estradiol, estrone, and estrone sulfate following a single 2 mg oral dose of micronized estradiol.png 1,976 × 1,312; 259 KB
Levels of estriol with administration of 8 mg oral estriol or 0.5 mg vaginal estriol in women.png 1,666 × 1,148; 226 KB
Levels of medroxyprogesterone acetate with 2.5 or 5 mg per day oral medroxyprogesterone acetate in postmenopausal women.png 2,200 × 1,087; 318 KB
Levels of progesterone after a single intramuscular injection of different doses of progesterone in postmenopausal women.png 1,676 × 1,145; 214 KB
Mean estradiol levels with 1 to 8 mg per day oral estradiol in transgender women.png 1,560 × 1,273; 100 KB
Mean plasma bicalutamide levels with 10 to 200 mg per day bicalutamide.png 2,262 × 1,140; 242 KB
Mean plasma bicalutamide levels with 10 to 600 mg per day bicalutamide in men.png 1,562 × 1,136; 214 KB
Mean plasma bicalutamide levels with 300 to 600 mg per day bicalutamide.png 1,881 × 1,144; 209 KB
Medroxyprogesterone acetate levels after a single 150 mg intramuscular injection of medroxyprogesterone acetate in women.png 1,679 × 1,098; 162 KB
Medroxyprogesterone acetate levels after a single intramuscular injection of different doses of medroxyprogesterone acetate in women.png 1,674 × 1,094; 240 KB
Medroxyprogesterone acetate levels with a subcutaneous injection of 104 mg medroxyprogesterone acetate in women.png 1,685 × 1,097; 148 KB
Naltrexone levels following an intramuscular injection of 380 mg naltrexone in microspheres.png 2,110 × 1,280; 123 KB
Naltrexone levels with a 50 mg oral dose of naltrexone at steady state.png 2,031 × 1,227; 95 KB
Nandrolone levels after a single 100 mg intramuscular injection of nandrolone esters.png 1,676 × 1,094; 270 KB
Nandrolone levels after a single intramuscular injection of different doses of nandrolone decanoate.png 1,947 × 1,375; 254 KB
Nandrolone levels with a single dose of nandrolone decanoate or nandrolone hexyloxyphenylpropionate by intramuscular injection in men.png 1,692 × 1,094; 219 KB
Norethisterone and ethinylestradiol levels after a single intramuscular injection of 200 mg norethisterone enanthate in premenopausal women.png 1,798 × 1,124; 98 KB
Norethisterone and ethinylestradiol levels after a single oral dose of 10 mg norethisterone acetate in postmenopausal women.png 1,790 × 1,118; 224 KB
Peak normalized-concentrations of suvorexant and lemborexant with administration at steady state in humans.png 1,073 × 647; 65 KB
Progesterone levels after a single dose of 50 or 100 mg sublingual progesterone in women.png 1,655 × 1,130; 254 KB
Progesterone levels after a single intramuscular or subcutaneous injection of 100 mg progesterone in an aqueous or oil solution in postmenopausal women.png 1,882 × 1,154; 272 KB
Progesterone levels after a single oral dose of 200 mg progesterone with food in postmenopausal women.png 1,665 × 1,136; 179 KB
Progesterone levels after a single subcutaneous injection of different doses of an aqueous solution of progesterone complexed with β-cyclodextrin in postmenopausal women.png 1,886 × 1,152; 251 KB
Progesterone levels following a single dose of oral or vaginal micronized progesterone determined with RIA or LC–MS in postmenopausal women.png 1,423 × 1,102; 225 KB
Progesterone levels measured via LC–MS–MS with 200 mg per day oral progesterone or 80 mg per day topical progesterone in postmenopausal women.png 1,664 × 1,133; 192 KB
Progesterone levels measured via RIA after a single oral dose of 200 mg progesterone with or without food in postmenopausal women.png 1,626 × 1,108; 197 KB
Progesterone levels with 100 mg oral progesterone in postmenopausal women.png 1,563 × 1,097; 213 KB
Progesterone levels with 100 mg rectal or vaginal progesterone in women.png 1,661 × 1,142; 202 KB
Progesterone levels with a single 25 or 100 mg rectal suppository in women.png 1,742 × 1,391; 287 KB
Progesterone levels with different doses of oral micronized progesterone in postmenopausal women.png 1,558 × 1,101; 222 KB
Progesterone levels with different preparations of oral progesterone in human volunteers.png 1,696 × 1,108; 221 KB
Progesterone levels with oral progesterone at different particle sizes in postmenopausal women.png 1,692 × 1,112; 235 KB
Progesterone levels with single intramuscular injections of different doses of progesterone in oil solution in women.png 1,935 × 1,129; 274 KB
Progesterone levels with six 100 mg progesterone pellets in women.png 2,006 × 1,215; 139 KB
Progesterone levels with vaginal progesterone suppositories in women.png 1,697 × 1,108; 233 KB
Progesterone, allopregnanolone, and pregnanolone levels with 200 mg oral progesterone or 400 mg vaginal progesterone.png 1,696 × 1,428; 148 KB
SHBG levels with polyestradiol phosphate, ethinylestradiol, and orchiectomy.png 1,653 × 1,119; 76 KB
Simulation of vortioxetine accumulation during oral vortioxetine therapy without or without an intravenous bolus of vortioxetine.png 1,740 × 1,149; 374 KB
Spironolactone and metabolite levels after a single oral dose of 100 mg spironolactone.png 1,676 × 1,151; 97 KB
Suvorexant levels with single and multiple doses of 10, 20, 40, 80, and 100 mg oral suvorexant in healthy men.webp 814 × 268; 29 KB
Testosterone and luteinizing hormone levels with 100 mg per day oral cyproterone acetate in men.png 1,565 × 1,109; 232 KB
Testosterone levels as a function of estradiol levels during oral estradiol therapy in transgender women.png 1,565 × 1,271; 146 KB
Testosterone levels following a single oral dose of 300 mg crystalline or micronized DHEA in premenopausal women.png 1,678 × 1,150; 198 KB
Testosterone levels in long-term androgen deprivation therapy with different GnRH agonists.png 1,635 × 1,101; 110 KB
Testosterone levels in men with prostate cancer treated with GnRH agonists and antagonists.png 1,626 × 1,101; 125 KB
Testosterone levels with 10 mg per day oral cyproterone acetate in men.png 1,467 × 1,117; 150 KB
Testosterone levels with 10 to 200 mg per day bicalutamide monotherapy in men.png 1,561 × 1,090; 224 KB
Testosterone levels with 10, 30, and 50 mg per day bicalutamide monotherapy in men.png 1,568 × 1,094; 187 KB
Testosterone levels with 100 to 300 mg per day oral cyproterone acetate and 0.1 mg per day diethylstilbestrol in men.png 1,447 × 1,101; 181 KB
Testosterone levels with 300 mg per week cyproterone acetate and 100 mg per month estradiol undecylate by intramuscular injection.png 1,458 × 1,153; 106 KB
Testosterone levels with 5 or 10 mg per day oral cyproterone acetate in men.png 1,689 × 1,018; 222 KB
Testosterone levels with 50 mg per day allylestrenol or 50 mg per day chlormadinone acetate over 12 weeks in men with benign prostatic hyperplasia.png 1,275 × 1,150; 156 KB
Testosterone levels with different doses of dienogest and cyproterone acetate in men.png 1,569 × 1,115; 303 KB
Testosterone levels with intramuscular injection of polyestradiol phosphate once every 4 weeks.png 1,653 × 1,119; 98 KB
Testosterone levels with intramuscular injection of testosterone esters in hypogonadal men.png 1,648 × 1,127; 182 KB
Testosterone levels with rectal administration of a 40 mg testosterone suppository in men.png 1,448 × 1,121; 148 KB
Trough estradiol levels and MADRS scores with sublingual estradiol in women with postpartum depression.png 1,695 × 1,093; 192 KB
Vaginal cornification with a single intramuscular injection of different estradiol esters in women.png 2,148 × 1,414; 379 KB
Vortioxetine levels after a single 10 mg oral dose of vortioxetine in fasted and fed healthy Japanese adults.png 1,921 × 1,165; 103 KB

Category:Medication time–concentration curves

Media in category "Medication time–concentration curves"

Navigation menu